We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
+18.38%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$533M
AUM Growth
+$60.8M
Cap. Flow
-$5.17M
Cap. Flow %
-0.97%
Top 10 Hldgs %
34.62%
Holding
127
New
21
Increased
12
Reduced
51
Closed
17

Top Buys

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$9.47M
2
CNC icon
Centene
CNC
+$9.11M
3
CTAS icon
Cintas
CTAS
+$8.31M
4
PGR icon
Progressive
PGR
+$8.01M
5
LLY icon
Eli Lilly
LLY
+$7.79M

Sector Composition

Rank Sector Weight
1 Healthcare 28.53%
2 Technology 28.17%
3 Financials 13.94%
4 Consumer Discretionary 11.92%
5 Industrials 7.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GHDX
51
DELISTED
Genomic Health, Inc.
GHDX
$3.29M 0.62%
+46,900
New +$2.74M
DHR icon
52
Danaher
DHR
$135B
$3.27M 0.61%
33,896
EW icon
53
Edwards Lifesciences
EW
$49.3B
$3.22M 0.6%
55,500
-114,000
-67% -$5.58M
BRK.B icon
54
Berkshire Hathaway Class B
BRK.B
$1.07T
$2.93M 0.55%
13,700
ALXN
55
DELISTED
Alexion Pharmaceuticals
ALXN
$2.78M 0.52%
19,996
HSIC icon
56
Henry Schein
HSIC
$9.78B
$2.77M 0.52%
41,578
-510
-1% -$31.8K
SYK icon
57
Stryker
SYK
$126B
$2.73M 0.51%
15,350
-15,600
-50% -$2.66M
CPRI icon
58
Capri Holdings
CPRI
$1.8B
$2.65M 0.5%
+38,600
New +$2.7M
SBUX icon
59
Starbucks
SBUX
$119B
$2.61M 0.49%
45,900
-600
-1% -$31.7K
SYY icon
60
Sysco
SYY
$39.7B
$2.6M 0.49%
+35,500
New +$2.56M
MASI
61
DELISTED
Masimo
MASI
$2.48M 0.46%
19,900
-200
-1% -$22.2K
MCHP icon
62
Microchip Technology
MCHP
$43B
$2.47M 0.46%
62,700
-800
-1% -$35.3K
MMM icon
63
3M
MMM
$89.1B
$2.39M 0.45%
13,576
-191
-1% -$32.9K
RHI icon
64
Robert Half
RHI
$3.66B
$2.31M 0.43%
+32,900
New +$2.41M
AOS icon
65
A.O. Smith
AOS
$8.38B
$2.29M 0.43%
43,000
-900
-2% -$52.8K
MKSI icon
66
MKS Inc
MKSI
$22.7B
$2.22M 0.42%
27,700
-250
-0.9% -$22.8K
NFLX icon
67
Netflix
NFLX
$291B
$2.18M 0.41%
58,300
-381,500
-87% -$13.8M
NBIX icon
68
Neurocrine Biosciences
NBIX
$17.6B
$2.08M 0.39%
16,900
GWRE icon
69
Guidewire Software
GWRE
$11.6B
$2.03M 0.38%
20,100
-13,700
-41% -$1.32M
ATO icon
70
Atmos Energy
ATO
$29.9B
$2.01M 0.38%
21,400
-900
-4% -$83.1K
GILD icon
71
Gilead Sciences
GILD
$162B
$1.96M 0.37%
25,375
-900
-3% -$68K
CCI icon
72
Crown Castle
CCI
$33.2B
$1.82M 0.34%
16,350
ESRX
73
DELISTED
Express Scripts Holding Company
ESRX
$1.82M 0.34%
19,155
-200
-1% -$17K
VZ icon
74
Verizon
VZ
$190B
$1.82M 0.34%
34,015
NKE icon
75
Nike
NKE
$62.1B
$1.46M 0.27%
17,200
-100
-0.6% -$8.03K

Similar funds

De Burlo Group's Q3 2018 Portfolio in Review

As of Q3 2018, De Burlo Group held 127 positions worth $533M, up 13% from $472M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

De Burlo Group's Q3 2018 filing shows 21 new, 12 increased, 51 reduced and 17 closed positions. Its largest new stake was TJX Companies: 184,400 shares worth $10.3M. The largest sale was Netflix, an estimated $13.8M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 32% a quarter earlier, followed by Technology and Financials.

  • De Burlo Group's largest Q3 2018 buy was TJX Companies: 184,400 shares worth $10.3M.
  • De Burlo Group added most to Illumina in Q3 2018, an estimated $7.66M increase.
  • De Burlo Group's biggest Q3 2018 reduction was Netflix, cutting an estimated $13.8M.
  • De Burlo Group fully exited Proofpoint, Inc. in Q3 2018, selling an estimated $9.77M.
  • De Burlo Group's ten largest holdings make up 35% of its $533M portfolio in Q3 2018.
  • De Burlo Group opened 21 new positions and closed 17 in Q3 2018.
  • De Burlo Group's portfolio value rose 13% quarter-over-quarter to $533M.

Based on De Burlo Group's 13F filing for Q3 2018, filed 8 Nov 2018.